Utah Retirement Systems Novavax Inc Transaction History

Utah Retirement Systems

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$18.2 - $76.12 $1,820 - $7,612	100 Added 0.74%	13,600 $248,000
Q1 2022 May 13, 2022	SELL	$69.73 - $142.9 $13,946 - $28,580	-200 Reduced 1.46%	13,500 $995,000
Q4 2021 Feb 14, 2022	BUY	$134.56 - $217.97 $53,824 - $87,188	400 Added 3.01%	13,700 $1.96 Million
Q3 2021 Nov 16, 2021	BUY	$177.8 - $270.58 $1.69 Million - $2.57 Million	9,500 Added 250.0%	13,300 $2.76 Million
Q2 2021 Aug 16, 2021	BUY	$121.0 - $257.67 $459,800 - $979,146	3,800 New	3,800 $807,000

290

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $666M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Utah Retirement Systems, based on Form 13F filings with the SEC.

Stay updated on Utah Retirement Systems with notifications on news.